Back to results
US 8,476,249 B2Granted
Method of treating thrombocytopenia
AssigneeGlaxoSmithKline LLC
InventorsConnie L. Erickson-Miller, Michael Arning
Life of this patent
Estimating the term…
Abstract
Invented is a method of treating thrombocytopenia in a human, in need thereof which comprises the in vivo administration of a therapeutically effective amount of a peptide or a non-peptide TPO receptor agonist and an anti-clotting agent or agents, and optional further active ingredients, to such human.
Claims4
A combination of agents comprising:
- 3′-{N′-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2′-hydroxybiphenyl-3-carboxylic acid or a pharmaceutically acceptable salt thereof and an anti-clotting agent.
Dependencies are inferred from the claim text.